Whalesbook
Shalby Ltd Achieves Profitability in Q4 FY26
Shalby Limited announced its financial results for the fourth quarter ended March 31, 2026. The company reported a significant turnaround, posting a consolidated net profit of ₹18.5 crore against a net loss of ₹12.2 crore in the same period last year. Consolidated revenue increased by 9.4% year-on-year to ₹295.5 crore. Consolidated EBITDA also saw a substantial jump of 43.1% to ₹37.4 crore, with operating margins improving to 12.7% from 9.7% a year earlier.
Positive Financial Shift
This performance signals a positive development for Shalby Limited, highlighting improved operational efficiency and profitability. The shift from a loss-making position to profit is a key positive for investors. The company's MedTech segment, which focuses on implants, emerged as a strong growth driver, recording a 45% year-on-year revenue increase. This suggests successful diversification into higher-margin businesses.
Business Segments and Performance
The 'Hospitals, Pharma & Franchise' segment remains the company's primary revenue generator, accounting for over 79% of total revenue. The Shalby MedTech division is noted for its robust growth, contributing significantly to the quarter's financial gains.
Key Concerns for Investors
Despite the profit turnaround, investors will be closely watching the company's strategy for managing its consolidated net debt of ₹446.2 crore, which remains a significant financial concern. Furthermore, a 6.7% year-on-year decline in the total number of surgeries performed in its hospital operations requires monitoring, as a continued drop could affect core revenue streams.
Operational Metrics
In Q4 FY26, Shalby's hospital operations served 21,551 in-patients and 1,22,887 out-patients. The occupancy rate improved to 48%, and the total number of surgeries performed was 6,909.
Future Focus
Looking ahead, investors will be keen to see continued profitable growth and effective debt reduction strategies. The performance of the MedTech segment is expected to be crucial for future expansion, while sustained patient volumes and surgical activity in hospital operations will be important indicators.